Top compounds associated with response to TLL2


Feature Type Standardized
Nominal ANOVA
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA tigecycline CTRPv2 pan-cancer AAC 0.063 0.2
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.043 0.2
mRNA ML258 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.062 0.2
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA etomoxir CTRPv2 pan-cancer AAC 0.049 0.2
Download CSV